UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS). 

Large UK hospital to tear up paper records amid digitisation...

A hospital in the UK is preparing to scrap its old paper records and replace them with a new digital system that aims to improve efficiency.

MHRA says Avastin can be used for AMD despite Bayer, Novarti...

Conference brochure for the inaugural Respiratory Drug Deliv...

Conference brochure for the inaugural Respiratory Drug

Working with EU is 'preferred option' post-Brexit says MHRA ...

The outgoing chief executive of the UK’s drugs regulator has said that the country’s “preferred option” is to continue working with the European regulator after Brexit – although there are

Market access roundup: UK HTA shakeups as Brexit fears deepe...

With a Brexit deal still out of sight, there have been intensified warnings in the UK about potential disruptions to medicine supplies that could follow a no-deal scenario.